1. Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 16:31-41, 1976
2. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130:461-470, 1999
3. Levey AS, Greene T, Kusek JW, Beck GJ, Group MS: A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol 11:155A, 2000 (abstr)
4. Schwartz GJ, Brion LP, Spitzer A: The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am 34:571-590, 1987
5. Stevens LA, Levey AS: Measurement of kidney function. Med Clin North Am 89:457-473, 2005
6. Mohler JL, Barton SD, Blouin RA, Cowen DL, Flanigan RC: The evaluation of creatinine clearance in spinal cord injury patients. J Urol 136:366-369, 1986
7. Gonwa TA, Jennings L, Mai ML, Stark PC, Levey AS, Klintmalm GB: Estimation of glomerular filtration rates before and after orthotopic liver transplantation: Evaluation of current equations. Liver Transpl 10:301-309, 2004
8. Sherman DS, Fish DN, Teitelbaum I: Assessing renal function in cirrhotic patients: Problems and pitfalls. Am J Kidney Dis 41:269-278, 2003
9. Jafar TH, Schmid CH, Levey AS: Serum creatinine as marker of kidney function in South Asians: A study of reduced GFR in adults in Pakistan. J Am Soc Nephrol 16:1413-1419, 2005
10. Moss AH: Shared decision-making in dialysis: The new RPA/ASN guideline on appropriate initiation and withdrawal of treatment. Am J Kidney Dis 37:1081-1091, 2001
11. Moss AH: Too many patients who are too sick to benefit start chronic dialysis: Nephrologists need to learn to “just say no”. Am J Kidney Dis 41:723-727, 2003
12. Galla JH: Clinical practice guideline on shared decision-making in the appropriate initiation of and withdrawal from dialysis. The Renal Physicians Association and the American Society of Nephrology. J Am Soc Nephrol 11:1340-1342, 2000
13. Moss AH, Holley JL, Davison SN, et al: Palliative care. Am J Kidney Dis 43:172-173, 2004
14. Levin A, Lewis M, Mortiboy P, et al: Multidisciplinary predialysis programs: Quantification and limitations of their impact on patient outcomes in two Canadian settings. Am J Kidney Dis 29:533-540, 1997
15. Lopes AA, Bragg J, Young E, et al: Depression as a predictor of mortality and hospitalization among hemodialysis patients in the United States and Europe. Kidney Int 62:199-207, 2002
16. Arora P, Obrador GT, Ruthazer R, et al: Prevalence, predictors, and consequences of late nephrology referral at a tertiary care center. J Am Soc Nephrol 10:1281-1286, 1999
17. Astor BC, Eustace JA, Powe NR, et al: Timing of nephrologist referral and arteriovenous access use: The CHOICE Study. Am J Kidney Dis 38:494-501, 2001
18. Avorn J, Bohn RL, Levy E, et al: Nephrologist care and mortality in patients with chronic renal insufficiency. Arch Intern Med 162:2002-2006, 2002
19. Avorn J, Winkelmayer WC, Bohn RL, et al: Delayed nephrologist referral and inadequate vascular access in patients with advanced chronic kidney failure. J Clin Epidemiol 55:711-716, 2002
20. Levey AS, Coresh J, Balk E, et al: National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, classification, and stratification. Ann Intern Med 139:137-147, 2003
21. Keshaviah PR, Emerson PF, Nolph KD: Timely initiation of dialysis: A urea kinetic approach. Am J Kidney Dis 33:344-348, 1999
22. Nolph KD: Rationale for early incremental dialysis with continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 13:S117-S119, 1998 (suppl 6)
23. Tattersall J, Greenwood R, Farrington K: Urea kinetics and when to commence dialysis. Am J Nephrol 15:283-289, 1995
24. US Renal Data System: USRDS 2004 Annual Data Report. The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2004
25. Ellis PA, Reddy V, Bari N, Cairns HS: Late referral of end-stage renal failure. QJM 91:727-732, 1998
26. Ifudu O, Dawood M, Homel P, Friedman EA: Timing of initiation of uremia therapy and survival in patients with progressive renal disease. Am J Nephrol 18:193-198, 1998
27. Roubicek C, Brunet P, Huiart L, et al: Timing of nephrology referral: Influence on mortality and morbidity. Am J Kidney Dis 36:35-41, 2000
28. Sesso R, Belasco AG: Late diagnosis of chronic renal failure and mortality on maintenance dialysis. Nephrol Dial Transplant 11:2417-2420, 1996
29. Fink JC, Burdick RA, Kurth SJ, et al: Significance of serum creatinine values in new end-stage renal disease patients. Am J Kidney Dis 34:694-701, 1999
30. Korevaar JC, Jansen MA, Dekker FW, et al: When to initiate dialysis: Effect of proposed US guidelines on survival. Lancet 358:1046-1050, 2001
31. Traynor JP, Simpson K, Geddes CC, Deighan CJ, Fox JG: Early initiation of dialysis fails to prolong survival in patients with end-stage renal failure. J Am Soc Nephrol 13:2125-2132, 2002
31A. The Renal Association UK Registry. The Sixth Annual Report, December 2003. This report was prepared by Dr David Ansell, Professor Terry Feest, Dr Catherine Byrne, and Dr Azhar Ahmad. Accessed July 31, 2005
32. US Renal Data System: USRDS 2003 Annual Data Report. The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2003
33. Curtis BM, Barret BJ, Jindal K, et al: Canadian survey of clinical status at dialysis initiation 1998-1999: A multicenter prospective survey. Clin Nephrol 58:282-288, 2002
34. Cooper BA, Branley P, Bulfone L, et al: The Initiating Dialysis Early and Late (IDEAL) Study: Study rationale and design. Perit Dial Int 24:176-181, 2004
35. Clinical practice guidelines for nutrition in chronic renal failure. KDOQI, National Kidney Foundation. Am J Kidney Dis 35:S1-140, 2000
36. Churchill DN, Thorpe KE, Nolph KD, Keshaviah PR, Oreopoulos DG, Page D: Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. The Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol 9:1285-1292, 1998
37. Bargman JM, Thorpe KE, Churchill DN: Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: A reanalysis of the CANUSA Study. J Am Soc Nephrol 12:2158-2162, 2001
38. Paniagua R, Amato D, Vonesh E, et al: Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol 13:1307-1320, 2002
39. Lo WK, Ho YW, Li CS, et al: Effect of Kt/V on survival and clinical outcome in CAPD patients in a randomized prospective study. Kidney Int 64:649-656, 2003
40. Paniagua R, Amato D, Vonesh E, Guo A, Mujais S: Health-related quality of life predicts outcomes but is not affected by peritoneal clearance: The ADEMEX trial. Kidney Int 67:1093-1104, 2005
41. Szeto CC, Wong TY, Leung CB, et al: Importance of dialysis adequacy in mortality and morbidity of Chinese CAPD patients. Kidney Int 58:400-407, 2000
42. Diaz-Buxo JA, Lowrie EG, Lew NL, Zhang SM, Zhu X, Lazarus JM: Associates of mortality among peritoneal dialysis patients with special reference to peritoneal transport rates and solute clearance. Am J Kidney Dis 33:523-534, 1999
43. Rocco MV, Frankenfield DL, Prowant B, Frederick P, Flanigan MJ: Risk factors for early mortality in U.S. peritoneal dialysis patients: Impact of residual renal function. Perit Dial Int 22:371-379, 2002
44. Termorshuizen F, Korevaar JC, Dekker FW, van Manen JG, Boeschoten EW, Krediet RT: The relative importance of residual renal function compared with peritoneal clearance for patient survival and quality of life: An analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2. Am J Kidney Dis 41:1293-1302, 2003
45. Chung SH, Heimburger O, Stenvinkel P, Qureshi AR, Lindholm B: Association between residual renal function, inflammation and patient survival in new peritoneal dialysis patients. Nephrol Dial Transplant 18:590-597, 2003
46. Jager KJ, Merkus MP, Dekker FW, et al: Mortality and technique failure in patients starting chronic peritoneal dialysis: Results of The Netherlands Cooperative Study on the Adequacy of Dialysis. NECOSAD Study roup. Kidney Int 55:1476-1485, 1999
47. Merkus MP, Jager KJ, Dekker FW, de Haan RJ, Boeschoten EW, Krediet RT: Predictors of poor outcome in chronic dialysis patients: The Netherlands Cooperative Study on the Adequacy of Dialysis. The NECOSAD Study Group. Am J Kidney Dis 35:69-79, 2000
48. Ates K, Nergizoglu G, Keven K, et al: Effect of fluid and sodium removal on mortality in peritoneal dialysis patients. Kidney Int 60:767-776, 2001
49. Wang AY, Wang M, Woo J, et al: Inflammation, residual kidney function, and cardiac hypertrophy are interrelated and combine adversely to enhance mortality and cardiovascular death risk of peritoneal dialysis patients. J Am Soc Nephrol 15:2186-2194, 2004
50. Goldfarb-Rumyantzev AS, Baird BC, Leypoldt JK, Cheung AK: The association between BP and mortality in patients on chronic peritoneal dialysis. Nephrol Dial Transplant 20:1693-1701, 2005
51. Utas C: Patient and technique survival on CAPD in Turkey. Perit Dial Int 21:602-606, 2001
52. Wang AY, Sanderson J, Sea MM, et al: Important factors other than dialysis adequacy associated with inadequate dietary protein and energy intakes in patients receiving maintenance peritoneal dialysis. Am J Clin Nutr 77:834-841, 2003
53. Szeto CC, Wong TY, Chow KM, Leung CB, Li PK: Oral sodium bicarbonate for the treatment of metabolic acidosis in peritoneal dialysis patients: A randomized placebo-control trial. J Am Soc Nephrol 14:2119-2126, 2003
54. Eustace JA, Coresh J, Kutchey C, et al: Randomized double-blind trial of oral essential amino acids for dialysis-associated hypoalbuminemia. Kidney Int 57:2527-2538, 2000
55. Gonzalez-Espinoza L, Gutierrez-Chavez J, del Campo FM, et al: Randomized, open label, controlled clinical trial of oral administration of an egg albumin-based protein supplement to patients on continuous ambulatory peritoneal dialysis. Perit Dial Int 25:173-180, 2005
56. Teixido-Planas J, Ortiz A, Coronel F, et al: Oral protein-energy supplements in peritoneal dialysis: A multicenter study. Perit Dial Int 25:163-172, 2005
57. Jones CH, Wells L, Stoves J, Farquhar F, Woodrow G: Can a reduction in extracellular fluid volume result in increased serum albumin in peritoneal dialysis patients? Am J Kidney Dis 39:872-875, 2002
58. Szeto CC, Wong TY, Chow KM, Leung CB, Law MC, Li PK: Independent effects of renal and peritoneal clearances on the mortality of peritoneal dialysis patients. Perit Dial Int 24:58-64, 2004
59. Bernardini J, Piraino B: Measuring compliance with prescribed exchanges in CAPD and CCPD patients. Perit Dial Int 17:338-342, 1997
60. Sevick MA, Levine DW, Burkart JM, Rocco MV, Keith J, Cohen SJ: Measurement of continuous ambulatory peritoneal dialysis prescription adherence using a novel approach. Perit Dial Int 19:23-30, 1999
61. Blake PG, Korbet SM, Blake R, et al: A multicenter study of noncompliance with continuous ambulatory peritoneal dialysis exchanges in US and Canadian patients. Am J Kidney Dis 35:506-514, 2000
62. Wazny LD, Stojimirovic BB, Heidenheim P, Blake PG: Factors influencing erythropoietin compliance in peritoneal dialysis patients. Am J Kidney Dis 40:623-628, 2002
63. Bernardini J, Piraino B: Compliance in CAPD and CCPD patients as measured by supply inventories during home visits. Am J Kidney Dis 31:101-107, 1998
64. Kutner NG, Zhang R, McClellan WM, Cole SA: Psychosocial predictors of non-compliance in haemodialysis and peritoneal dialysis patients. Nephrol Dial Transplant 17:93-99, 2002
65. Canada-USA (CANUSA) Peritoneal Dialysis Study Group: Adequacy of dialysis and nutrition in continuous peritoneal dialysis: Association with clinical outcomes. J Am Soc Nephrol 7:198-207, 1996
66. Lutes R, Perlmutter J, Holley JL, Bernardini J, Piraino B: Loss of residual renal function in patients on peritoneal dialysis. Adv Perit Dial 9:165-168, 1993
67. Szeto CC, Wong TY, Chow KM, et al: Impact of dialysis adequacy on the mortality and morbidity of anuric Chinese patients receiving continuous ambulatory peritoneal dialysis. J Am Soc Nephrol 12:355-360, 2001
68. Szeto CC, Lai KN, Wong TY, et al: Independent effects of residual renal function and dialysis adequacy on nutritional status and patient outcome in continuous ambulatory peritoneal dialysis. Am J Kidney Dis 34:1056-1064, 1999
69. Szeto CC, Wong TY, Chow KM, Leung CB, Li PK: Are peritoneal dialysis patients with and without residual renal function equivalent for survival study? Insight from a retrospective review of the cause of death. Nephrol Dial Transplant 18:977-982, 2003
70. Lo WK, Lui SL, Chan TM, et al: Minimal and optimal peritoneal Kt/V targets: Results of an anuric peritoneal dialysis patient's survival analysis. Kidney Int 67:2032-2038, 2005
71. Brown EA, Davies SJ, Rutherford P, et al: Survival of functionally anuric patients on automated peritoneal dialysis: The European APD Outcome Study. J Am Soc Nephrol 14:2948-2957, 2003
72. Jansen MA, Termorshuizen F, Korevaar JC, Dekker FW, Boeschoten E, Krediet RT: Predictors of survival in anuric peritoneal dialysis patients. Kidney Int 68:1199-1205, 2005
73. Bhaskaran S, Schaubel DE, Jassal SV, et al: The effect of small solute clearances on survival of anuric peritoneal dialysis patients. Perit Dial Int 20:181-187, 2000
74. Szeto CC, Wong TY, Chow KM, et al: The impact of increasing the daytime dialysis exchange frequency on peritoneal dialysis adequacy and nutritional status of Chinese anuric patients. Perit Dial Int 22:197-203, 2002
75. Lye WC, Chan PS, Leong SO, van der Straaten JC: Psychosocial and psychiatric morbidity in patients on CAPD. Adv Perit Dial 13:134-136, 1997
76. Wuerth D, Finkelstein SH, Ciarcia J, Peterson R, Kliger AS, Finkelstein FO: Identification and treatment of depression in a cohort of patients maintained on chronic peritoneal dialysis. Am J Kidney Dis 37:1011-1017, 2001
77. Bargman JM, Bick J, Cartier P, et al: Guidelines for adequacy and nutrition in peritoneal dialysis. Canadian Society of Nephrology. J Am Soc Nephrol 10:S311-S321, 1999 (suppl 13)
77A. CARI (Caring for Australasians with Renal Impairment) PD Guidelines. Updated January 11, 2006. Copyright 2004, CARI
77B. The Renal Association Treatment of Adults and Children with Renal Failure Standards and Audit Measures, 3rd edition. Prepared by the Standards and Audit Subcommittee of the Renal Association on behalf of the Renal Association and the Royal College of Physicians of London in collaboration with the British Transplantation Society, the Intensive Care Society and the British Association of Paediatric Nephrologists.
78. Dombros N, Dratwa M, Feriani M, et al: European best practice guidelines for peritoneal dialysis. 7: Adequacy of peritoneal dialysis. Nephrol Dial Transplant 20:ix24-ix27, 2005 (suppl 9)
79. Rocco M, Soucie JM, Pastan S, McClellan WM: Peritoneal dialysis adequacy and risk of death. Kidney Int 58:446-457, 2000
80. Lo WK, Tong KL, Li CS, et al: Relationship between adequacy of dialysis and nutritional status, and their impact on patient survival on CAPD in Hong Kong. Perit Dial Int 21:441-447, 2001
81. Davies SJ, Phillips L, Russell GI: Peritoneal solute transport predicts survival on CAPD independently of residual renal function. Nephrol Dial Transplant 13:962-968, 1998
82. Perez RA, Blake PG, Spanner E, et al: High creatinine excretion ratio predicts a good outcome in peritoneal dialysis patients. Am J Kidney Dis 36:362-367, 2000
83. Park HC, Kang SW, Choi KH, Ha SK, Han DS, Lee HY: Clinical outcome in continuous ambulatory peritoneal dialysis patients is not influenced by high peritoneal transport status. Perit Dial Int 21:S80-S85, 2001 (suppl 3)
84. Aslam N, Bernardini J, Fried L, Piraino B: Peritoneal dialysis clearance can replace residual renal function. Perit Dial Int 21:263-268, 2001
85. Tonbul Z, Altintepe L, Sozlu C, Yeksan M, Yildiz A, Turk S: The association of peritoneal transport properties with 24-hour blood pressure levels in CAPD patients. Perit Dial Int 23:46-52, 2003
86. Woodrow G, Oldroyd B, Stables G, Gibson J, Turney JH, Brownjohn AM: Effects of icodextrin in automated peritoneal dialysis on blood pressure and bioelectrical impedance analysis. Nephrol Dial Transplant 15:862-866, 2000
87. Menon MK, Naimark DM, Bargman JM, Vas SI, Oreopoulos DG: Long-term blood pressure control in a cohort of peritoneal dialysis patients and its association with residual renal function. Nephrol Dial Transplant 16:2207-2213, 2001
88. Wang AY, Wang M, Woo J, et al: A novel association between residual renal function and left ventricular hypertrophy in peritoneal dialysis patients. Kidney Int 62:639-647, 2002
89. Singhal MK, Bhaskaran S, Vidgen E, Bargman JM, Vas SI, Oreopoulos DG: Rate of decline of residual renal function in patients on continuous peritoneal dialysis and factors affecting it. Perit Dial Int 20:429-438, 2000
90. Sarnak MJ, Levey AS, Schoolwerth AC, et al: Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 108:2154-2169, 2003
91. Eknoyan G, Beck GJ, Cheung AK, et al: Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 347:2010-2019, 2002
92. Foley RN, Parfrey PS: Cardiovascular disease and mortality in ESRD. J Nephrol 11:239-245, 1998
93. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia): Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. Lancet 349:1857-1863, 1997
94. Brenner BM, Cooper ME, de Zeeuw D, et al: Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 345:861-869, 2001
95. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med 329:1456-1462, 1993
96. Lewis EJ, Hunsicker LG, Clarke WR, et al: Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 345:851-860, 2001
97. Parving HH, Lehnert H, Brochner-Mortensen J, Gomis R, Andersen S, Arner P: The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med 345:870-878, 2001
98. Moist LM, Port FK, Orzol SM, et al: Predictors of loss of residual renal function among new dialysis patients. J Am Soc Nephrol 11:556-564, 2000
99. Li PK, Chow KM, Wong TY, Leung CB, Szeto CC: Effects of an angiotensin-converting enzyme inhibitor on residual renal function in patients receiving peritoneal dialysis. A randomized, controlled study. Ann Intern Med 139:105-112, 2003
100. Suzuki H, Kanno Y, Sugahara S, Okada H, Nakamoto H: Effects of an angiotensin II receptor blocker, valsartan, on residual renal function in patients on CAPD. Am J Kidney Dis 43:1056-1064, 2004
101. Shin SK, Noh H, Kang SW, et al: Risk factors influencing the decline of residual renal function in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 19:138-142, 1999
102. Shemin D, Maaz D, St Pierre D, Kahn SI, Chazan JA: Effect of aminoglycoside use on residual renal function in peritoneal dialysis patients. Am J Kidney Dis 34:14-20, 1999
103. Baker RJ, Senior H, Clemenger M, Brown EA: Empirical aminoglycosides for peritonitis do not affect residual renal function. Am J Kidney Dis 41:670-675, 2003
104. Kshirsagar AV, Poole C, Mottl A, et al: N-Acetylcysteine for the prevention of radiocontrast induced nephropathy: A meta-analysis of prospective controlled trials. J Am Soc Nephrol 15:761-769, 2004
105. Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W: Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 343:180-184, 2000
106. Gunal AI, Duman S, Ozkahya M, et al: Strict volume control normalizes hypertension in peritoneal dialysis patients. Am J Kidney Dis 37:588-593, 2001
107. Jansen MA, Hart AA, Korevaar JC, Dekker FW, Boeschoten EW, Krediet RT: Predictors of the rate of decline of residual renal function in incident dialysis patients. Kidney Int 62:1046-1053, 2002
108. Jassal SV, Lok CE, Walele A, Bargman JM: Continued transplant immunosuppression may prolong survival after return to peritoneal dialysis: Results of a decision analysis. Am J Kidney Dis 40:178-183, 2002
109. Bhatla B, Moore HL, Nolph KD: Modification of creatinine clearance by estimation of residual urinary creatinine and urea clearance in CAPD patients. Adv Perit Dial 11:101-105, 1995
110. Rodby RA, Firanek CA, Cheng YG, Korbet SM: Reproducibility of studies of peritoneal dialysis adequacy. Kidney Int 50:267-271, 1996
111. Johnson DW, Mudge DW, Sturtevant JM, et al: Predictors of decline of residual renal function in new peritoneal dialysis patients. Perit Dial Int 23:276-283, 2003
112. Foley RN, Parfrey PS, Sarnak MJ: Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32:S112-S119, 1998 (suppl 3)
113. Multiple Risk Factor Intervention Trial Research Group: Multiple Risk Factor Intervention Trial. Risk factor changes and mortality results. JAMA 248:1465-1477, 1982
114. Konings CJ, Kooman JP, Schonck M, et al: Fluid status, blood pressure, and cardiovascular abnormalities in patients on peritoneal dialysis. Perit Dial Int 22:477-487, 2002
115. Sharma AP, Blake PG: Should “fluid removal” be used as an adequacy target in peritoneal dialysis? Perit Dial Int 23:107-108, 2003
116. Harnett JD, Foley RN, Kent GM, Barre PE, Murray D, Parfrey PS: Congestive heart failure in dialysis patients: Prevalence, incidence, prognosis and risk factors. Kidney Int 47:884-890, 1995
117. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE: Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease. Kidney Int 49:1379-1385, 1996
118. Mahon A, Fan SL: Accuracy of ultrafiltration volume measurements for patients on peritoneal dialysis. Perit Dial Int 25:92-93, 2005
119. Medcalf JF, Harris KP, Walls J: Role of diuretics in the preservation of residual renal function in patients on continuous ambulatory peritoneal dialysis. Kidney Int 59:1128-1133, 2001
120. Davies SJ, Brown EA, Frandsen NE, et al: Longitudinal membrane function in functionally anuric patients treated with APD: Data from EAPOS on the effects of glucose and icodextrin prescription. Kidney Int 67:1609-1615, 2005
121. Davies SJ, Phillips L, Naish PF, Russell GI: Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis. J Am Soc Nephrol 12:1046-1051, 2001
122. Davies SJ, Woodrow G, Donovan K, et al: Icodextrin improves the fluid status of peritoneal dialysis patients: Results of a double-blind randomized controlled trial. J Am Soc Nephrol 14:2338-2344, 2003
123. Konings CJ, Kooman JP, Schonck M, et al: Effect of icodextrin on volume status, blood pressure and echocardiographic parameters: A randomized study. Kidney Int 63:1556-1563, 2003
124. Rodriguez-Carmona A, Fontan MP: Sodium removal in patients undergoing CAPD and automated peritoneal dialysis. Perit Dial Int 22:705-713, 2002
125. Rodriguez-Carmona A, Perez-Fontan M, Garca-Naveiro R, Villaverde P, Peteiro J: Compared time profiles of ultrafiltration, sodium removal, and renal function in incident CAPD and automated peritoneal dialysis patients. Am J Kidney Dis 44:132-145, 2004
126. de Fijter CW, Oe LP, Nauta JJ, et al: Clinical efficacy and morbidity associated with continuous cyclic compared with continuous ambulatory peritoneal dialysis. Ann Intern Med 120:264-271, 1994
127. Finkelstein FO, Sorkin M, Cramton CW, Nolph K: Initiatives in peritoneal dialysis: Where do we go from here? Perit Dial Int 11:274-278, 1991
128. Schaubel DE, Blake PG, Fenton SS: Trends in CAPD technique failure: Canada, 1981-1997. Perit Dial Int 21:365-371, 2001
129. Woodrow G, Turney JH, Brownjohn AM: Technique failure in peritoneal dialysis and its impact on patient survival. Perit Dial Int 17:360-364, 1997
130. Krishnan M, Thodis E, Ikonomopoulos D, et al: Predictors of outcome following bacterial peritonitis in peritoneal dialysis. Perit Dial Int 22:573-581, 2002
131. Piraino B, Bailie GR, Bernardini J, et al: Peritoneal dialysis-related infections recommendations: 2005 Update. Perit Dial Int 25:107-131, 2005
132. Troidle L, Gorban-Brennan N, Kliger A, Finkelstein FO: Continuous peritoneal dialysis-associated peritonitis: A review and current concepts. Semin Dial 16:428-437, 2003
133. Flanigan M, Gokal R: Peritoneal catheters and exit-site practices toward optimum peritoneal access: A review of current developments. Perit Dial Int 25:132-139, 2005
134. Gokal R, Alexander S, Ash S, et al: Peritoneal catheters and exit-site practices toward optimum peritoneal access: 1998 Update. (Official report from the International Society for Peritoneal Dialysis). Perit Dial Int 18:11-33, 1998
135. Thodis E, Passadakis P, Ossareh S, Panagoutsos S, Vargemezis V, Oreopoulos DG: Peritoneal catheter exit-site infections: Predisposing factors, prevention and treatment. Int J Artif Organs 26:698-714, 2003
136. Strippoli GF, Tong A, Johnson D, Schena FP, Craig JC: Catheter-related interventions to prevent peritonitis in peritoneal dialysis: A systematic review of randomized, controlled trials. J Am Soc Nephrol 15:2735-2746, 2004
137. Einwohner R, Bernardini J, Fried L, Piraino B: The effect of depressive symptoms on survival in peritoneal dialysis patients. Perit Dial Int 24:256-263, 2004
138. Kimmel PL, Peterson RA, Weihs KL, et al: Multiple measurements of depression predict mortality in a longitudinal study of chronic hemodialysis outpatients. Kidney Int 57:2093-2098, 2000
139. Lopes AA, Albert JM, Young EW, et al: Screening for depression in hemodialysis patients: Associations with diagnosis, treatment, and outcomes in the DOPPS. Kidney Int 66:2047-2053, 2004
140. Mapes DL, Lopes AA, Satayathum S, et al: Health-related quality of life as a predictor of mortality and hospitalization: The Dialysis Outcomes and Practice Patterns Study (DOPPS). Kidney Int 64:339-349, 2003
141. Troidle L, Watnick S, Wuerth DB, Gorban-Brennan N, Kliger AS, Finkelstein FO: Depression and its association with peritonitis in long-term peritoneal dialysis patients. Am J Kidney Dis 42:350-354, 2003
142. Lew SQ, Piraino B: Quality of life and psychological issues in peritoneal dialysis patients. Semin Dial 18:119-123, 2005
143. Wuerth D, Finkelstein SH, Finkelstein FO: The identification and treatment of depression in patients maintained on dialysis. Semin Dial 18:142-146, 2005
144. Rubin HR, Fink NE, Plantinga LC, Sadler JH, Kliger AS, Powe NR: Patient ratings of dialysis care with peritoneal dialysis vs hemodialysis. JAMA 291:697-703, 2004
145. Wuerth DB, Finkelstein SH, Schwetz O, Carey H, Kliger AS, Finkelstein FO: Patients' descriptions of specific factors leading to modality selection of chronic peritoneal dialysis or hemodialysis. Perit Dial Int 22:184-190, 2002
146. Schaefer F, Langenbeck D, Heckert KH, Scharer K, Mehls O: Evaluation of peritoneal solute transfer by the peritoneal equilibration test in children. Adv Perit Dial 8:410-415, 1992
147. Warady BA, Alexander SR, Hossli S, et al: Peritoneal membrane transport function in children receiving long-term dialysis. J Am Soc Nephrol 7:2385-2391, 1996
148. Morgenstern BZ, Wuhl E, Nair KS, Warady BA, Schaefer F: Anthropometric prediction of total body water in children who are on pediatric peritoneal dialysis. J Am Soc Nephrol 17:285-293, 2006
149. Verrina E, Brendolan A, Gusmano R, Ronco C: Chronic renal replacement therapy in children: Which index is best for adequacy? Kidney Int 54:1690-1696, 1998
150. de Boer AW, van Schaijk TC, Willems HL, Reddingius RE, Monnens LA, Schroder CH: The necessity of adjusting dialysate volume to body surface area in pediatric peritoneal equilibration tests. Perit Dial Int 17:199-202, 1997
151. Schaefer F, Haraldsson B, Haas S, Simkova E, Feber J, Mehls O: Estimation of peritoneal mass transport by three-pore model in children. Kidney Int 54:1372-1379, 1998
152. Warady BA, Alexander S, Hossli S, Vonesh E, Geary D, Kohaut E: The relationship between intraperitoneal volume and solute transport in pediatric patients. Pediatric Peritoneal Dialysis Study Consortium. J Am Soc Nephrol 5:1935-1939, 1995
153. Morgenstern BZ: Peritoneal equilibration in children. Perit Dial Int 16:S532-S539, 1996 (suppl 1)
154. Warady BA, Fivush B, Andreoli SP, et al: Longitudinal evaluation of transport kinetics in children receiving peritoneal dialysis. Pediatr Nephrol 13:571-576, 1999
155. Warady BA, Morgenstern B, Alexander SR: Peritoneal dialysis, in Pediatric Nephrology. Philadelphia, PA, Lippincott Williams & Wilkins, 2004, pp 1375-1394
156. Warady BA, Watkins SL, Fivush BA, et al: Validation of PD Adequest 2.0 for pediatric dialysis patients. Pediatr Nephrol 16:205-211, 2001
157. The Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents. Pediatrics 114:S555-S576, 2004 (suppl 2)
158. National Kidney Foundation: KDOQI Clinical Practice Guidelines for Cardiovascular Disease in Dialysis Patients. Am J Kidney Dis 45:S1-S153, 2005 (suppl 3)
159. Mitsnefes M, Stablein D: Hypertension in pediatric patients on long-term dialysis: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Am J Kidney Dis 45:309-315, 2005
160. Mitsnefes MM, Daniels SR, Schwartz SM, Meyer RA, Khoury P, Strife CF: Severe left ventricular hypertrophy in pediatric dialysis: Prevalence and predictors. Pediatr Nephrol 14:898-902, 2000
161. Robinson RF, Nahata MC, Sparks E, et al: Abnormal left ventricular mass and aortic distensibility in pediatric dialysis patients. Pediatr Nephrol 20:64-68, 2005
162. Holtta T, Happonen JM, Ronnholm K, Fyhrquist F, Holmberg C: Hypertension, cardiac state, and the role of volume overload during peritoneal dialysis. Pediatr Nephrol 16:324-331, 2001
163. de Boer AW, Schroder CH, van Vliet R, Willems JL, Monnens LA: Clinical experience with icodextrin in children: Ultrafiltration profiles and metabolism. Pediatr Nephrol 15:21-24, 2000
164. Rusthoven E, Krediet RT, Willems HL, Monnens LA, Schroder CH: Peritoneal transport characteristics with glucose polymer-based dialysis fluid in children. J Am Soc Nephrol 15:2940-2947, 2004
165. Dart A, Feber J, Wong H, Filler G: Icodextrin re-absorption varies with age in children on automated peritoneal dialysis. Pediatr Nephrol 20:683-685, 2005
166. National Kidney Foundation: KDOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease. Am J Kidney Dis 43:S1-S290, 2004 (suppl 1)
167. North American Pediatric Renal Transplant Cooperative Study (NAPRTCS) 2005 Annual Report. Boston, MA, NAPRTCS Administrative Office, 2005
168. Furth SL, Hwang W, Yang C, Neu AM, Fivush BA, Powe NR: Growth failure, risk of hospitalization and death for children with end-stage renal disease. Pediatr Nephrol 17:450-455, 2002
168A. Mahan JD, Warady BA, on behalf of the Growth in Children with CKD Consensus Committee: Assessment and treatment of short stature in pediatric patients with chronic kidney disease: A consensus statement. Pediatr Nephrol 2006 (in press)
169. Proceedings of the IPNA Seventh Symposium on Growth and Development in Children with Chronic Kidney Disease: The Molecular Basis of Skeletal Growth. April 1-3, 2004. Heidelberg, Germany. Pediatr Nephrol 20:249-440, C247-C211, 2005
170. Greenbaum LA, Del Rio M, Bamgbola F, Kaskel F: Rationale for growth hormone therapy in children with chronic kidney disease. Adv Chronic Kidney Dis 11:377-386, 2004
171. Kaskel F: Chronic renal disease: A growing problem. Kidney Int 64:1141-1151, 2003
172. Warady BA, Alexander SR, Watkins S, Kohaut E, Harmon WE: Optimal care of the pediatric end-stage renal disease patient on dialysis. Am J Kidney Dis 33:567-583, 1999
173. Neu AM, Ho PL, McDonald RA, Warady BA: Chronic dialysis in children and adolescents. The 2001 NAPRTCS Annual Report. Pediatr Nephrol 17:656-663, 2002
173A. Elhalel-Dranitzki M, Rubinger D, Moscovici A, Haviv YS, Friedlaender MM, Silver J, Popovtzer MM: CAPD to improve quality of life in patients with refractory heart failure. Nephrol Dial Transplant 13:3041-3042, 1998
173B. Hebert MJ, Falardeau M, Pichette V, Houde M, Nolin L, Cardinal J, Ouimet D: Continuous ambulatory peritoneal dialysis for patients with severe left ventricular systolic dysfunction and end-stage renal disease. Am J Kidney Dis 25:761-768, 1995
173C. Konig P, Geissler D, Lechleitner P, Spielberger M, Dittrich P: Improved management of congestive heart failure. Use of continuous ambulatory peritoneal dialysis. Arch Intern Med 147:1031-1034, 1987
173D. McKinnie JJ, Bourgeois RJ, Husserl FE: Long-term therapy for heart failure with continuous ambulatory peritoneal dialysis. Arch Intern Med 145:1128-1129, 1985
173E. Ortiz AM, Acosta PA, Corbalan R, Jalil JE: Long-term automated peritoneal dialysis in patients with refractory congestive heart failure. Adv Perit Dial 19:77-80, 2003
173F. Rubin J, Ball R: Continuous ambulatory peritoneal dialysis as treatment of severe congestive heart failure in the face of chronic renal failure. Report of eight cases. Arch Intern Med 146:1533-1535, 1986
173G. Golper TA: Incremental dialysis. J Am Soc Nephrol 9:S107-111, 1998
173H. Mehrotra R, Nolph KD, Gotch F: Early initiation of chronic dialysis: role of incremental dialysis. Perit Dial Int 17:426-430, 1997
173I. Bonomini V, Feletti C, Scolari MP, Stefoni S: Benefits of early initiation of dialysis. Kidney Int Suppl 17:S57-59, 1985
173J. Burkart JM, Satko SG: Incremental initiation of dialysis: one center's experience over a two-year period. Perit Dial Int 20:418-422, 2000
173K. De Vecchi AF, Scalamogna A, Finazzi S, Colucci P, Ponticelli C: Preliminary evaluation of incremental peritoneal dialysis in 25 patients. Perit Dial Int 20:412-417, 2000
173L. Neri L, Viglino G, Cappelletti A, Gandolfo C, Barbieri S: Incremental dialysis with automated peritoneal dialysis. Adv Perit Dial 19:93-96, 2003
173M. Tzamaloukas AH: Incremental initiation of peritoneal dialysis: current practice. Adv Perit Dial 15:175-178, 1999
173N. Williams PF: Timely initiation of dialysis. Am J Kidney Dis 34:594-595, 1999
174. Davies SJ, Russell L, Bryan J, Phillips L, Russell GI: Comorbidity, urea kinetics, and appetite in continuous ambulatory peritoneal dialysis patients: Their interrelationship and prediction of survival. Am J Kidney Dis 26:353-361, 1995
175. Mak SK, Wong PN, Lo KY, Tong GM, Fung LH, Wong AK: Randomized prospective study of the effect of increased dialytic dose on nutritional and clinical outcome in continuous ambulatory peritoneal dialysis patients. Am J Kidney Dis 36:105-114, 2000
176. Uribarri J, Dimaano F, London RD, Dowling J, Marcus RG: Increase in Kt/V increased serum albumin but not nPCR in a group of patients on continuous peritoneal dialysis. Perit Dial Int 17:511-513, 1997
177. Harty J, Boulton H, Faragher B, Venning M, Gokal R: The influence of small solute clearance on dietary protein intake in continuous ambulatory peritoneal dialysis patients: A methodologic analysis based on cross-sectional and prospective studies. Am J Kidney Dis 28:553-560, 1996
178. Cheng LT, Tang W, Wang T: Strong association between volume status and nutritional status in peritoneal dialysis patients. Am J Kidney Dis 45:891-902, 2005
179. Herzig KA, Purdie DM, Chang W, et al: Is C-reactive protein a useful predictor of outcome in peritoneal dialysis patients? J Am Soc Nephrol 12:814-821, 2001
180. Arkouche W, Fouque D, Pachiaudi C, et al: Total body water and body composition in chronic peritoneal dialysis patients. J Am Soc Nephrol 8:1906-1914, 1997
181. Woodrow G, Oldroyd B, Turney JH, Davies PS, Day JM, Smith MA: Measurement of total body water and urea kinetic modelling in peritoneal dialysis. Clin Nephrol 47:52-57, 1997
182. Dahl NV, Foote EF, Kapoian T, Steward CA, Sherman RA: Measuring total body water in peritoneal dialysis patients using an ethanol dilution technique. Kidney Int 56:2297-2303, 1999
183. Johansson AC, Samuelsson O, Attman PO, Bosaeus I, Haraldsson B: Limitations in anthropometric calculations of total body water in patients on peritoneal dialysis. J Am Soc Nephrol 12:568-573, 2001
184. Jones MR: Etiology of severe malnutrition: Results of an international cross-sectional study in continuous ambulatory peritoneal dialysis patients. Am J Kidney Dis 23:412-420, 1994
185. Tzamaloukas AH, Murata GH: Estimating urea volume in amputees on peritoneal dialysis by modified anthropometric formulas. Adv Perit Dial 12:143-146, 1996
186. Wong KC, Xiong DW, Kerr PG, et al: Kt/V in CAPD by different estimations of V. Kidney Int 48:563-569, 1995
187. Tzamaloukas AH, Murata GH, Piraino B, et al: The relation between body size and normalized small solute clearances in continuous ambulatory peritoneal dialysis. J Am Soc Nephrol 10:1575-1581, 1999
188. Keshaviah PR, Nolph KD, Moore HL, et al: Lean body mass estimation by creatinine kinetics. J Am Soc Nephrol 4:1475-1485, 1994
189. Lo WK, Prowant BF, Moore HL, et al: Comparison of different measurements of lean body mass in normal individuals and in chronic peritoneal dialysis patients. Am J Kidney Dis 23:74-85, 1994
190. Gilbert R, Gokal RK: The gastrointestinal system, in Eknoyan G, Knochel JP (eds): The Systemic Consequences of Renal Failure. New York, NY, Grune & Stratton, 1984, p 133
191. Ikizler TA, Wingard RL, Hakim RM: Malnutrition in peritoneal dialysis patients: Etiologic factors and treatment options. Perit Dial Int 15:S63-S66, 1995 (suppl 5)
192. Hylander B, Barkeling B, Rossner S: What contributes to poor appetite in CAPD patients? Perit Dial Int 11:S117, 1991 (suppl 1; abstr)
193. Hylander B, Barkeling B, Rossner S: Appetite and eating behavior—A comparison between CAPD patients, HD patients, and healthy controls. Perit Dial Int 12:S137A, 1992 (suppl 1; abstr)
194. Lindholm B, Bergstrom J: Nutritional management of patients undergoing peritoneal dialysis, in Nolph KD (ed): Peritoneal Dialysis (ed 3). Boston, MA, Kluwer, 1989, pp 230-260
195. Bannister DK, Acchiardo SR, Moore LW, Kraus AP Jr: Nutritional effects of peritonitis in continuous ambulatory peritoneal dialysis (CAPD) patients. J Am Diet Assoc 87:53-56, 1987
196. Acchiardo SR, Moore LW, Latour PA: Malnutrition as the main factor in morbidity and mortality of hemodialysis patients. Kidney Int Suppl 16:S199-S203, 1983
197. Degoulet P, Legrain M, Reach I, et al: Mortality risk factors in patients treated by chronic hemodialysis. Report of the Diaphane collaborative study. Nephron 31:103-110, 1982
198. Lowrie EG, Lew NL: Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 15:458-482, 1990
199. Held PJ, Port FK, Agadoa LYC: Survival Probabilities and Causes of Death. Bethesda, MD, National Institutes of Health, NIDDKD, 1991, pp 31-40
200. Enia G, Sicuso C, Alati G, Zoccali C: Subjective global assessment of nutrition in dialysis patients. Nephrol Dial Transplant 8:1094-1098, 1993
201. Kopple JD, Jones MR, Keshaviah PR, et al: A proposed glossary for dialysis kinetics. Am J Kidney Dis 26:963-981, 1995
202. Harty JC, Boulton H, Curwell J, et al: The normalized protein catabolic rate is a flawed marker of nutrition in CAPD patients. Kidney Int 45:103-109, 1994
203. Health Care Financing Administration: 2000 Annual Report, End-Stage Renal Disease Clinical Performance Measures Project. Baltimore, MD, Department of Health and Human Services, Health Care Financing Administration, Office of Clinical Standards and Quality, 2000
204. Blumenkrantz MJ, Kopple JD, Moran JK, Coburn JW: Metabolic balance studies and dietary protein requirements in patients undergoing continuous ambulatory peritoneal dialysis. Kidney Int 21:849-861, 1982
205. Diamond SM, Henrich WL: Nutrition and peritoneal dialysis, in Mitch WE, Klahr S (eds): Nutrition and the Kidney. Boston, MA, Little, Brown, 1988, pp 198-223
206. Bergstrom J, Lindholm B: Nutrition and adequacy of dialysis. How do hemodialysis and CAPD compare? Kidney Int Suppl 40:S39-S50, 1993
207. Nolph KD: What's new in peritoneal dialysis—An overview. Kidney Int Suppl 38:S148-S152, 1992
208. Lim VS, Flanigan MJ: Protein intake in patients with renal failure: Comments on the current NKF-DOQI guidelines for nutrition in chronic renal failure. Semin Dial 14:150-152, 2001
209. Uribarri J, Levin NW, Delmez J, et al: Association of acidosis and nutritional parameters in hemodialysis patients. Am J Kidney Dis 34:493-499, 1999
210. Juergensen PH, Gorban-Brennan N, Finkelstein FO: Compliance with the dialysis regimen in chronic peritoneal dialysis patients: Utility of the pro card and impact of patient education. Adv Perit Dial 20:90-92, 2004
211. Twardowski ZJ, Nolph KD, Khanna R, et al: Peritoneal equilibration test. Perit Dial Bull 7:138-147, 1987
212. Blake P, Burkart JM, Churchill DN, et al: Recommended clinical practices for maximizing peritoneal dialysis clearances. Perit Dial Int 16:448-456, 1996
213. Burkart JM, Schreiber M, Korbet SM, et al: Solute clearance approach to adequacy of peritoneal dialysis. Perit Dial Int 16:457-470, 1996
214. Davies SJ: Monitoring of long-term peritoneal membrane function. Perit Dial Int 21:225-230, 2001
215. Pannekeet MM, Imholz AL, Struijk DG, et al: The standard peritoneal permeability analysis: A tool for the assessment of peritoneal permeability characteristics in CAPD patients. Kidney Int 48:866-875, 1995
216. Ho-dac-Pannekeet MM, Atasever B, Struijk DG, Krediet RT: Analysis of ultrafiltration failure in peritoneal dialysis patients by means of standard peritoneal permeability analysis. Perit Dial Int 17:144-150, 1997
217. Haraldsson B: Assessing the peritoneal dialysis capacities of individual patients. Kidney Int 47:1187-1198, 1995
218. Mujais S, Nolph K, Gokal R, et al: Evaluation and management of ultrafiltration problems in peritoneal dialysis. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis. Perit Dial Int 20:S5-S21, 2000 (suppl 4)
219. Rocco MV, Jordan JR, Burkart JM: Changes in peritoneal transport during the first month of peritoneal dialysis. Perit Dial Int 15:12-17, 1995
220. Johnson DW, Mudge DW, Blizzard S, et al: A comparison of peritoneal equilibration tests performed 1 and 4 weeks after PD commencement. Perit Dial Int 24:460-465, 2004
221. Davies SJ, Phillips L, Griffiths AM, Russell LH, Naish PF, Russell GI: What really happens to people on long-term peritoneal dialysis? Kidney Int 54:2207-2217, 1998
222. Heimburger O, Waniewski J, Werynski A, Tranaeus A, Lindholm B: Peritoneal transport in CAPD patients with permanent loss of ultrafiltration capacity. Kidney Int 38:495-506, 1990
223. Krediet RT: The physiology of peritoneal solute transport and ultrafiltration, in Gokal R, Khanna R, Krediet RT, Nolph K (eds): Textbook of Peritoneal Dialysis. Dordrecht, The Netherlands, Kluwer, 2000, pp 135-172
224. Virga G, Amici G, da Rin G, et al: Comparison of fast peritoneal equilibration tests with 1.36 and 3.86% dialysis solutions. Blood Purif 12:113-120, 1994
225. Pride ET, Gustafson J, Graham A, et al: Comparison of a 2.5% and a 4.25% dextrose peritoneal equilibration test. Perit Dial Int 22:365-370, 2002
226. Smit W, van Dijk P, Langedijk MJ, et al: Peritoneal function and assessment of reference values using a 3.86% glucose solution. Perit Dial Int 23:440-449, 2003
227. Rubin J, Ray R, Barnes T, Bower J: Peritoneal abnormalities during infectious episodes of continuous ambulatory peritoneal dialysis. Nephron 29:124-127, 1981
228. Krediet RT, Zuyderhoudt FM, Boeschoten EW, Arisz L: Alterations in the peritoneal transport of water and solutes during peritonitis in continuous ambulatory peritoneal dialysis patients. Eur J Clin Invest 17:43-52, 1987
229. Panasiuk E, Pietrzak P, Klos M, Wankowicz Z: Characteristics of peritoneum after peritonitis in CAPD patients. Adv Perit Dial 4:42-45, 1988
230. Brophy DF, Sowinski KM, Kraus MA, Moe SM, Klaunig JE, Mueller BA: Small and middle molecular weight solute clearance in nocturnal intermittent peritoneal dialysis. Perit Dial Int 19:534-539, 1999
231. National Kidney Foundation: KDOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease, 2000. Am J Kidney Dis 37:S182-S238, 2001 (suppl 1)
232. American Academy of Pediatrics: National Cholesterol Education Program: Report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. Pediatrics 89:525-584, 1992
233. National Kidney Foundation: KDOQI Clinical Practice Guidelines for Management of Dyslipidemias in Patients With Kidney Disease. Am J Kidney Dis 41:S1-S91, 2003 (suppl 3)
234. Morton KA, Pisani DE, Whiting JH Jr, Cheung AK, Arias JM, Valdivia S: Determination of glomerular filtration rate using technetium-99m-DTPA with differing degrees of renal function. J Nucl Med Technol 25:110-114, 1997
235. Perrone RD, Steinman TI, Beck GJ, et al: Utility of radioisotopic filtration markers in chronic renal insufficiency: Simultaneous comparison of 125I-iothalamate, 169Yb-DTPA, 99mTc-DTPA, and inulin. The Modification of Diet in Renal Disease Study. Am J Kidney Dis 16:224-235, 1990
236. Greenbaum LA, Schaefer F: The decision to initiate dialysis in children and adolescents, in Warady BA, Schaefer F, Fine RN, Alexander S (eds): Pediatric Dialysis. Dordrecht, The Netherlands, Kluwer, 2004, pp 177-195
237. Shemesh O, Golbetz H, Kriss JP, Myers BD: Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int 28:830-838, 1985
238. Lubowitz H, Slatopolsky E, Shankel S, Rieselbach RE, Bricker NS: Glomerular filtration rate. Determination in patients with chronic renal disease. JAMA 199:252-256, 1967
239. van Olden RW, Krediet RT, Struijk DG, Arisz L: Measurement of residual renal function in patients treated with continuous ambulatory peritoneal dialysis. J Am Soc Nephrol 7:745-750, 1996
240. Hellerstein S, Berenbom M, Alon US, Warady BA: Creatinine clearance following cimetidine for estimation of glomerular filtration rate. Pediatr Nephrol 12:49-54, 1998
241. Hellerstein S, Erwin P, Warady BA: The cimetidine protocol: A convenient, accurate, and inexpensive way to measure glomerular filtration rate. Pediatr Nephrol 18:71-72, 2003
242. Schwartz GJ, Haycock GB, Edelmann CM Jr, Spitzer A: A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 58:259-263, 1976
243. Seikaly MG, Loleh S, Rosenblum A, Browne R: Validation of the Center for Medicare and Medicaid Services algorithm for eligibility for dialysis. Pediatr Nephrol 19:893-897, 2004
244. Alexander SR, Warady BA: The demographics of dialysis in children, in Warady BA, Schaefer F, Fine RN, Alexander S (eds): Pediatric Dialysis. Dordrecht, The Netherlands, Kluwer, 2004, pp 35-45
245. Fine RN, Ho M: The role of APD in the management of pediatric patients: A report of the North American Pediatric Renal Transplant Cooperative Study. Semin Dial 15:427-429, 2002
246. Warady BA, Schaefer F, Alexander SR, Firanek C, Mujais S: Care of the pediatric patient on peritoneal dialysis: Clinical process for optimal outcomes. Deerfield, IL, Baxter Healthcare, 2004
246A. Goldstein SL, Graham N, Burwinkle T, Warady B, Farrah R, Varni JW: Health-related quality of life in pediatric patients with ESRD. Pediatr Nephrol 2006 (in press)
247. Watson AR, Gartland C: Avoiding and coping with patient and family burnout, in Fine RN, Alexander SR, Warady BA (eds): CAPD/CCPD in Children. Boston, MA, Kluwer, 1998, pp 491-506
248. Oreopoulos DG: Beyond Kt/V: Redefining adequacy of dialysis in the 21st century. Int Urol Nephrol 34:393-403, 2002
249. Wong CS, Hingorani S, Gillen DL, et al: Hypoalbuminemia and risk of death in pediatric patients with end-stage renal disease. Kidney Int 61:630-637, 2002
250. Chadha V, Blowey DL, Warady BA: Is growth a valid outcome measure of dialysis clearance in children undergoing peritoneal dialysis? Perit Dial Int 21:S179-S184, 2001 (suppl 3)
251. Holtta T, Ronnholm K, Jalanko H, Holmberg C: Clinical outcome of pediatric patients on peritoneal dialysis under adequacy control. Pediatr Nephrol 14:889-897, 2000
252. Chen HH, Shetty A, Afthentopoulos IE, Oreopoulos DG: Discrepancy between weekly KT/V and weekly creatinine clearance in patients on CAPD. Adv Perit Dial 11:83-87, 1995
253. Twardowski ZJ: Relationship between creatinine clearance and Kt/V in peritoneal dialysis: A response to the defense of the DOQI document. Perit Dial Int 19:199-203, 1999
254. Mellits ED, Cheek DB: The assessment of body water and fatness from infancy to adulthood. Monogr Soc Res Child Dev 35:12-26, 1970
255. Mendley SR, Majkowski NL, Schoeller DA: Validation of estimates of total body water in pediatric dialysis patients by deuterium dilution. Kidney Int 67:2056-2062, 2005
256. Morgenstern B, Nair KS, Lerner G, Neu A, Quan A, Warady BA: Impact of total body water errors on Kt/V estimates in children on peritoneal dialysis. Adv Perit Dial 17:260-263, 2001
257. Morgenstern BZ, Mahoney DW, Warady BA: Estimating total body water in children on the basis of height and weight: A reevaluation of the formulas of Mellits and Cheek. J Am Soc Nephrol 13:1884-1888, 2002
258. DuBois D, DuBois EF: A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med 17:863-871, 1916
259. Gehan EA, George SL: Estimation of human body surface area from height and weight. Cancer Chemother Rep 54:225-235, 1970
260. Fischbach M, Terzic J, Menouer S, et al: Effects of automated peritoneal dialysis on residual daily urinary volume in children. Adv Perit Dial 17:269-273, 2001
261. Wuhl E, Mehls O, Schaefer F: Antihypertensive and antiproteinuric efficacy of ramipril in children with chronic renal failure. Kidney Int 66:768-776, 2004
262. Phakdeekitcharoen B, Leelasa-nguan P: Effects of an ACE inhibitor or angiotensin receptor blocker on potassium in CAPD patients. Am J Kidney Dis 44:738-746, 2004
263. North American Pediatric Renal Transplant Cooperative Study (NAPRTCS) 2004 Annual Report. Boston, MA, NAPRTCS Administrative Office, 2004
264. Gerson A, Hwang W, Fiorenza J, et al: Anemia and health-related quality of life in adolescents with chronic kidney disease. Am J Kidney Dis 44:1017-1023, 2004
265. Gerson AC, Riley A, Fivush BA, et al: Assessing health status and health care utilization in adolescents with chronic kidney disease. J Am Soc Nephrol 16:1427-1432, 2005
266. Fischbach M, Terzic J, Laugel V, Escande B, Dangelser C, Helmstetter A: Measurement of hydrostatic intraperitoneal pressure: A useful tool for the improvement of dialysis dose prescription. Pediatr Nephrol 18:976-980, 2003
267. Parekh RS, Flynn JT, Smoyer WE, et al: Improved growth in young children with severe chronic renal insufficiency who use specified nutritional therapy. J Am Soc Nephrol 12:2418-2426, 2001
268. Montini G, Amici G, Milan S, et al: Middle molecule and small protein removal in children on peritoneal dialysis. Kidney Int 61:1153-1159, 2002
269. Fischbach M, Stefanidis CJ, Watson AR: Guidelines by an ad hoc European committee on adequacy of the paediatric peritoneal dialysis prescription. Nephrol Dial Transplant 17:380-385, 2002
270. Szeto CC, Chow KM, Kwan BC, et al: Hypokalemia in Chinese peritoneal dialysis patients: Prevalence and prognostic implication. Am J Kidney Dis 46:128-135, 2005
271. Chung SH, Heimburger O, Lindholm B, Lee HB: Peritoneal dialysis patient survival: A comparison between a Swedish and a Korean centre. Nephrol Dial Transplant 20:1207-1213, 2005
272. del Peso G, Fernandez-Reyes MJ, Hevia C, et al: Factors influencing peritoneal transport parameters during the first year on peritoneal dialysis: Peritonitis is the main factor. Nephrol Dial Transplant 20:1201-1206, 2005